Author

Robert C. Higham

Observed names: Higham, Robert, R Higham, R. Higham, R.C. Higham, Robert C Higham, Robert Higham, Robert C Higham

Observed institution: Sherman Oaks Hospital

ORCID: 0000-0002-6799-1799

Observed ORCID: 0000-0002-6799-1799

OpenAlex ID: A5013169089

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis

2022 · Mark G. Lebwohl, Leon H. Kircik, et al. · JAMA · 119

PDF

Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children

2024 · Eric L. Simpson, Lawrence F. Eichenfield, et al. · JAMA Dermatology · 70

Manifestations and Management of Difficult-to-Treat Psoriasis

2018 · Lakshi M. Aldredge, Robert C. Higham · Journal of the Dermatology Nurses’ Association · 60

The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study

2023 · Melinda Gooderham, Leon Kircik, et al. · Journal of Drugs in Dermatology · 47

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis

2023 · Matthew J. Zirwas, Zoe D. Draelos, et al. · JAMA Dermatology · 39

PDF

Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies

2022 · Archie W. Thurston, David W. Osborne, et al. · American Journal of Clinical Dermatology · 36

PDF

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study

2023 · Leon H Kircik, Javier Alonso-Llamazares, et al. · British Journal of Dermatology · 21

PDF

Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial

2024 · Linda Stein Gold, David N. Adam, et al. · Journal of the American Academy of Dermatology · 19

The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score

2021 · Kim A. Papp, Mark G. Lebwohl, et al. · Dermatology and Therapy · 18

PDF

Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( INTEGUMENT ‐ PED ): A Phase 3 Randomized Controlled Trial

2025 · Lawrence F. Eichenfield, Rocco Serrao, et al. · Pediatric Dermatology · 17

PDF

Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial

2025 · Eric L. Simpson, Lawrence F. Eichenfield, et al. · Dermatitis · 15

Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial

2022 · Linda Stein Gold, Javier Alonso-Llamazares, et al. · American Journal of Clinical Dermatology · 12

PDF

Managing inflammatory arthritides: Role of the nurse practitioner and physician assistant

2010 · Mary Lesko, Melodie Young, et al. · Journal of the American Academy of Nurse Practitioners · 11

Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials

2021 · Mark Lebwohl, Leon Kircik, et al. · SKIN The Journal of Cutaneous Medicine · 7

PDF

ONCE-DAILY ROFLUMILAST CREAM 0.15% FOR ATOPIC DERMATITIS: POOLED Results: FROM INTEGUMENT-1/2 PHASE 3 TRIALS

2023 · L. Eichenfield, M. Boguniewicz, et al. · Annals of Allergy Asthma & Immunology · 5

Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial

2023 · Zoe D Draelos, David N Adam, et al. · British Journal of Dermatology · 5

27874 Correlation of itch response to roflumilast cream with disease severity and patient-reported outcomes in patients with chronic plaque psoriasis

2021 · Linda Stein Gold, Javier Alonso-Llamazares, et al. · Journal of the American Academy of Dermatology · 5

The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study

2020 · Melinda J. Gooderham, Leon H. Kircik, et al. · SKIN The Journal of Cutaneous Medicine · 5

PDF

Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema

2024 · Zoe Diana Draelos, Robert C. Higham, et al. · Journal of Drugs in Dermatology · 4

Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States

2024 · April Armstrong, Melodie Young, et al. · Journal of Dermatological Treatment · 4

Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States

2024 · Teri Greiling, Melodie Young, et al. · Dermatology and Therapy · 4

Integration of moisturizers and cleansers into a busy dermatology practice.

2005 · Robert Higham · PubMed · 4

639 - Efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients 2 to 5 years of age with mild to moderate atopic dermatitis (INTEGUMENT-PED): a phase 3 randomized controlled trial

2024 · Lawrence Eichenfield, John Browning, et al. · British Journal of Dermatology · 3

Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study

2021 · Linda Stein Gold, Melinda Gooderham, et al. · SKIN The Journal of Cutaneous Medicine · 3

PDF

Roflumilast Cream 0.3% Improved the Severity and Impact of Itch in Patients With Chronic Plaque Psoriasis in the Phase 3 DERMIS-1 and DERMIS-2 Studies

2021 · Melinda Gooderham, Javier Alonso-Llamazares, et al. · SKIN The Journal of Cutaneous Medicine · 3

PDF

Works count: 69

Citation count: 557

H-index: 12

I10-index: 13